Evidence map›Paper›PMID 40766231›Full record

ArticleResearch square2025

Patient-Reported Barriers to Healthcare Access Among Patients with Gastrointestinal Cancer: Insights from 45,000 Participants in the All of Us Research Program.

Samuel D Butensky, Kurt S Schultz, Elizabeth L Godfrey, Jihoon Kim, Caroline H Johnson, Ira Leeds, Sajid A Khan

Abstract readPreprint
In one paragraph

Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Samuel D ButenskyYale New Haven Hospital.
Kurt S SchultzYale New Haven Hospital.
Elizabeth L GodfreyYale New Haven Hospital.
Jihoon KimYale University.
Caroline H JohnsonYale University.
Ira LeedsYale New Haven Hospital.
Sajid A KhanYale New Haven Hospital.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Pathology Tissue Services Shared ResourceP30CA016359 · NCI · YALE UNIVERSITY · PI MEGAN C KING · 1985 to 2026
$85.0M
Identification of metabolic niches in African Americans with colorectal cancerR21CA280372 · NCI · YALE UNIVERSITY · PI JOHNSON, CAROLINE HELEN, KHAN, SAJID A · 2024 to 2025
$431k
NCATS NIH HHS UL1 TR001863NCI NIH HHS P30 CA016359NCI NIH HHS R21 CA280372
6 · The paper itself

Abstract

Background: Gastrointestinal (GI) cancer patients often face care delays and cost-related unmet needs, increasing the probability for treatment nonadherence and adverse outcomes. The extent of these barriers within the first three months of diagnosis remains unclear. We aimed to identify early barriers to care for targeted interventions. Methods: A retrospective analysis using the Results: Among 45,061 GI cancer patients, 89.4% were underrepresented in biomedical research. Patients surveyed within three months of diagnosis had higher rates of delays in care (16.9% vs. 14.0%, p < 0.001), driven by affordability, childcare, and transportation (all p < 0.001). Overall cost-related unmet needs did not differ significantly (< 3 months 20.9% vs. >3 months 19.7%, p = 0.204), but differences in unmet prescription and alternative therapy needs persisted. After PSM, early-diagnosis patients had no differences in delays in care but were more likely to report cost-saving behaviors such as using lower-cost prescriptions (OR 1.28, 95% CI 1.05-1.54) and alternative therapies (OR 1.48, 95% CI 1.08-2.01) to save money. Conclusion: Cost-related unmet needs exist in the first three months after GI cancer diagnosis. This study underscores the importance of addressing social determinants of health early in cancer care.

Indexed as

All of UsCancerGastrointestinalHealthcare Access

Identifiers

PMID40766231
PMCPMC12324591

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.